Dr. Priyatha Garlapati, MD

Dr. Garlapati practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Garlapati's NPI, 1184101313, was assigned on July 20, 2018. Dr. Garlapati holds Oklahoma license 41161.

Dr. Garlapati's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Garlapati's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Garlapati is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic. Dmand AI also links Dr. Garlapati to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Garlapati practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Garlapati's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Garlapati is licensed in Oklahoma.

CMS data shows 227 Medicare services from Dr. Garlapati across 3 procedure codes in 2024, all of them office visits, for 106 Medicare patients. Medicare paid $22,698 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Dr. Garlapati in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Garlapati's median patient age at 68, with 77% women.

In 2024, Dr. Garlapati wrote 490 Medicare Part D claims for 116 patients. 82% of them were for generic drugs. CMS names the drug for 400 of them, across 15 drugs with 11 or more claims each, at $419,683 in total drug cost. In 2023, CMS named 189 claims across 8 drugs.

Dr. Garlapati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Garlapati as offering telehealth.

CMS Open Payments shows 359 general payments to Dr. Garlapati from 22 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,758.